AptaBio Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022
Period Ending	Apr '25 Apr 1, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	202,148	171,234	201,805	237,483
Market Cap Growth	-15.15%	-15.15%	-15.02%	-
Enterprise Value	178,154	146,945	152,862	-
Last Close Price	7520.00	6370.00	9050.00	10650.00
Forward PE	-	78.10	78.10	78.10
PS Ratio	52.67	50.95	623.11	4911.46
PB Ratio	3.73	3.16	3.29	4.54
P/TBV Ratio	3.16	3.16	3.32	4.54
EV/Sales Ratio	53.01	43.72	471.99	-
Debt / Equity Ratio	0.14	0.14	0.23	0.01
Asset Turnover	0.04	0.04	0.00	-
Quick Ratio	1.67	1.67	65.10	16.58
Current Ratio	1.79	1.79	70.27	19.63
Return on Equity (ROE)	-50.84%	-50.84%	-21.21%	-
Return on Assets (ROA)	-15.24%	-15.24%	-14.22%	-
Return on Capital (ROIC)	-18.90%	-18.90%	-16.50%	-
Earnings Yield	-14.53%	-17.16%	-5.98%	-4.45%
FCF Yield	-6.13%	-7.24%	-7.65%	-3.32%
Buyback Yield / Dilution	-3.83%	-3.83%	-1.72%	-

Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.